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Abstract
Background: Central hemodynamic indices have been demonstrated to correlate with coronary artery disease
(CAD). However, in the context of type 2 diabetes mellitus (DM), this correlation has not been fully illustrated.
Therefore, this study was employed to investigate the impact of DM on the correlation between aortic
augmentation index and the severity of coronary artery disease.
Methods: In this study, we analyzed 197 patients who underwent coronary angiography at Anzhen Hospital from
September 2015 to January 2016. Central hemodynamics were non-invasively measured with BPro® device (Health
STATS, Singapore). The severity of CAD was defined according to SYNTAX scores. Type 2 diabetes was defined
according to ADA guidelines. AIx@75 was defined as AIx normalized to a heart rate of 75 bpm. Receiver operating
characteristics (ROC) determined the optimal cut-off value of AIx@75 to predict moderate to severe CAD. Multivariate
logistic regression analysis evaluated the correlation between central hemodynamic parameters and CAD severity.
Results: Eighty-four (42.6 %) of the studied subjects were diabetic patients. Our findings were that (1) AIx@75 was
significantly correlated with SYNTAX. (ROC analyzed AUC: 0.638, 95 % CI 0.555–0.721, p < 0.05). The cut-off value of
AIx@75 to predict moderate-to-severe CAD as SYNTAX score more than 22 was 71.45. (2) In non-diabetic patients,
correlation analysis revealed that AIx@75, augmentation pressure and peak relative time were significantly correlated
with CAD severity (p < 0.05). After adjustment, AIx@75 remained as the only independent predictor of moderate-to-
severe CAD (odds ratio 1.099, 95 % CI 1.028–1.176, p < 0.05). (3) In diabetic patients, the correlation between central
hemodynamic parameters and the severity of CAD did not exist.
Conclusions: Aortic augmentation index was significantly related to the severity of CAD and was an independent
predictor of severe CAD. However, clinical practitioners should note that its value in DM populations was
compromised.
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Background
Central pressures are revealed to be better related to car-
diovascular events than are peripheral pressures [1]. Fur-
thermore, central pressures are pathologically more
relevant than peripheral pressures with CAD [2]. The
advancement of non-invasive techniques to measure
central blood pressure has allowed for safer and wider
application in more patients. Augmentation pressure
(AP), aortic augmentation index (AIx) and pulse wave
analysis-derived peak relative time (PRT) are markers of
arterial stiffness [3]. Recently, non-invasively measured
central hemodynamic parameters have been reported to
be related with CAD [4, 5]. However, no reliable cut-off
value for such parameters has been determined.
Type 2 diabetes mellitus (DM) is a common comor-
bidity for CAD. Diabetic patients with CAD demonstrate
accelerated progression of coronary atherosclerosis,
leading to worse clinical outcome [6]. Arterial stiffness
can increase in the presence of overt DM. Central
hemodynamics is significantly altered in diabetic pa-
tients [3, 7]. Yet whether the coexistence of DM ex-
erts any influence on the relationship between central
hemodynamic parameters and CAD remains unclear.
Previous studies have failed to elucidate the effect of co-
morbidities like type 2 diabetes mellitus on the correlation
between central hemodynamic indices and CAD. In view
of these considerations, we initiated the present study to
investigate the correlation between non-invasively mea-
sured central hemodynamic parameters and the severity
of CAD. Meanwhile, we explored in detail the influence of
type 2 diabetes on the correlation.
Methods
Study design and patient recruitment
The cross-sectional study was performed at Anzhen Hos-
pital in Beijing. We consecutively included patients who
underwent coronary angiography at our center from
September 2015 to January 2016. Exclusion criteria: 1. Pa-
tients without complete baseline data; 2. Patients whose
central pressure measurement was not readable; 3. Patients
who had previous coronary intervention or coronary artery
bypass grafting, atrial fibrillation, or hemodynamically
significant valvular heart disease were excluded. This
study was approved by the Institutional Ethics Com-
mittee of Anzhen Hospital and all subjects gave writ-
ten informed consent.
Measurement of blood pressure and pulse wave analysis
Noninvasive blood pressure and pulse wave analysis
were performed prior to coronary angiography with the
commercially available BPro® device with A-Pulse CASP
software (Health STATS, Singapore). The BPro® device
captured the radial waveform, which was subsequently
used to generate central systolic pressure by N-point
moving average method as described before [8]. Periph-
eral pressure waveforms were recorded from the wrist
using applanation tonometry. After 20 sequential
waveforms had been obtained, augmentation pressure
(AP), augmentation index (AIx) and peak relative time
(PRT) were derived from the measurement of PWA. The
central hemodynamic indices are illustrated in Fig. 1. AP
was defined as the difference between P1 and P2, AIx was
calculated as AP divided by pulse pressure and PRT
was described as T2T1 duration. Given that AIx is in-
versely related to heart rate, we used AIx normalized
to a heart rate of 75 bpm (AIx@75) as an alternative.
The BPro® device measured arterial pressure wave-
forms in 10s blocks over the course of 20–30s and
the first stable waveform block was used for data ana-
lysis. The experienced operator visually inspected the
waveforms for anomalies and selected the first stable
waveform block, which applied to the criteria of ad-
equate pulse height (100 mV) and pulse length vari-
ability (<20 %) [9]. Each patient was measured three
times to avoid bias.
Analysis of coronary angiography
Coronary angiography (CAG) was primarily performed
through the trans-radial approach with standardized
technique. To reach consensus, all coronary angiograms
were visually assessed by at least two experienced inter-
ventional cardiologists. The extent and severity of coron-
ary artery disease were determined by SYNTAX scores.
The anatomical SYNTAX score was calculated with on-
line calculator version 2.1 at www.syntaxscore.com. The
following is 12categorization of CAD severity assessed
by SYNTAX score according to guidelines: low as ≤22,
moderate as 23–32 and severe as ≥33 [10, 11].
Statistical analysis
The data were analyzed with the SPSS 15.0 software
(Chicago, IL, USA). Continuous variables were presented
as mean ± standard deviation (SD) and categorical variables
as percentages. Comparisons between groups were made
by using the unpaired student t test (two-tailed) or
Mann-Whitney U-test for continuous data and the
Pearson’s χ2- or Fisher’s exact test. Spearman’s correl-
ation coefficient (two-tailed) was used for the analysis
of the correlation between AIx and SYNTAX scores.
The receiver-operating characteristic curve was used to
evaluate the predictive accuracy of AIx@75 for moderate
to severe CAD; the highest Youden index (J statistic)
representing the maximum potential effectiveness was
used to determine the optimal cut-off AIx@75 value. Lo-
gistic regression analysis was employed for multivariate
and univariate analysis. A p value of <0.05 was considered
statistically significant.
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Results
Patient demographics
Our study consecutively enrolled 318 patients. A total of
85, 20 and 16 patients were excluded due to a history of
percutaneous coronary intervention, coronary bypass
grafting and atrial fibrillation, respectively. The analysis
of 197 participants compared 113 non-diabetic with 84
diabetic patients. Baseline characteristics are summa-
rized in Table 1. The mean age of subjects was 59.2 ±
11.1 years old, and 72.1 % were men. The distribution of
Fig. 1 Pressure waveform measurement. AIx = augmentation index PRT = peak relative time








Age(years) 59.2 ± 11.1 57.9 ± 11.0 60.9 ± 11.0 0.069
Gender(male), n(%) 142(72.1) 82(72.6) 59(70.2) 0.646
Hypertension, n(%) 128(65) 67(59.3) 61(72.6) 0.063
Hyperlipidemia, n(%) 45(22.8) 21(18.6) 24(28.6) 0.106
Current smokers, n(%) 101(51.3) 59(52.2) 41(48.8) 0.592
BMI(kg/m2) 25.2 ± 5.3 25.4 ± 4.9 25.1 ± 5.7 0.684
SYNTAX 16.4 ± 12.2 16.0 ± 11.9 17.0 ± 12.6 0.546
SYNTAX > 22, n(%) 60(30.5) 35(31.3) 25(29.8) 0.823
Lab data
HbA1c(%) 6.4 ± 1.2 5.7 ± 0.4 7.3 ± 1.3 <0.3*
Triglyceride(mmol/l) 1.8 ± 1.6 1.6 ± 0.8 2.0 ± 1.8 0.073
LDL cholesterol(mmol/l) 2.6 ± 1.0 2.6 ± 1.0 2.5 ± 1.0 0.775
HDL cholesterol(mmol/l) 1.1 ± 0.3 1.1 ± 0.3 1.1 ± 0.3 0.045*
Creatinine(μmol/l) 79.0 ± 17.6 77.8 ± 17.5 80.6 ± 17.7 0.260*
Medications
ACEI, n(%) 21(10.7) 11(9.7) 10(11.9) 0.641
ARB, n(%) 17(8.6) 6(5.3) 11(13.1) 0.057
β-blockers, n(%) 35(17.8) 21(18.6) 14(16.7) 0.706
Calcium channel blockers, n(%) 44(22.3) 14(12.4) 30(35.7) <0.3*
Statins, n(%) 32(16.2) 10(8.8) 22(26.2) 0.9*
*p value for comparison between the non-diabetic and diabetic groups; p < 0.05 indicates statistical significance. BMI body mass index, LDL low-density lipoprotein,
HDL high-density lipoprotein, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker
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hypertension, dyslipidemia and current smoking status
were not significantly different between groups (p > 0.05),
nor were laboratory findings and medications.
Central hemodynamic indices analysis
Table 2 shows the values of hemodynamic indices. Mean
values of central aortic systolic pressure (CASP), central
pulse pressure (central PP) and brachial pulse pressure
(brachial PP) were significantly higher in the diabetic
group (p < 0.05).
In the total patient group, univariate analysis revealed
that AIx@75 was significantly correlated with SYNTAX
score. AIx@75 value to predict the presence of moderate-
to-severe CAD was 71.45 (ROC defined AUC 0.638; sensi-
tivity 75 %, specificity 47 %, 95 % CI 0.555–0.721, p = 0.4).
In addition, the correlation between central hemodynamic
indices and SYNTAX score differed between groups:
univariate logistic analysis showed that higher AIx@75,
AP and lower PRT were significantly correlated with SYN-
TAX score in the non-diabetic group, but not correlated
in the diabetic group. Similarly, multivariate logistic ana-
lysis showed that higher AIx@75 was significantly corre-
lated with SYNTAX score in the non-diabetic group only
(Table 3). Figure 2 demonstrates the linear correlation
between AIx@75 and SYNTAX score categorized as
non-diabetic (R2 = 0.180, p < 0.3) and diabetic groups
(R2 = 0.4, p = 0.680).
Discussion
To the best of our knowledge, this is the first study inves-
tigating the impact of type 2 diabetes on the relationship
between non-invasively measured central hemodynamic
parameters and CAD.
Augmentation index and coronary artery disease
Cho SW et al. found that AIx was significantly associated
with the extent of CAD in the younger group [5]. Tanindi
A et al. demonstrated that AIx was correlated with more
severe CAD despite patients’ clinical presentation [12].
Similarly, we confirmed that AIx was positively correlated
with SYNTAX. Moreover, AIx is an independent predictor
of moderate-to-severe CAD. It has been well demon-
strated that augmentation index is a parameter reflecting
arterial stiffness. However, an established theory explain-
ing why the severity of atherosclerosis in CAD relates to
parameters of arterial stiffness is lacking. The concept of
bidirectional influence is a possible explanation, namely
elevated parameters of arterial stiffness are both a cause
and a consequence of atherosclerosis [5, 13]. On the one
hand, increased central BP pulsation promotes endothelial
damage, leading to the progress of atherosclerosis; On the
other hand, diffused atherosclerotic plaques impair the
elastic properties of the arterial wall. Physiologically, the
reflect wave arrives earlier in the aorta and augments pres-
sure in late systole as aortic stiffness increases. Augmenta-
tion of the aortic pressure wave is a manifestation of wave
reflection, which can be expressed as the AP [5]. A note-
worthy study focused on the time duration analysis and
unveiled that augmentation time ratio was related to the
presence of CAD [4]. Combined with our finding of the
relationship between peak relative time and the severity of
CAD, the theory that advanced atherosclerosis signifi-
cantly increases wave reflection is reasonable.
The role of diabetes mellitus
We categorized our patients into diabetic versus non-
diabetic groups and found that the predictive value of AIx
was profound in non-diabetic patients only. Our findings
are in line with Agnoletti D et al. [14] who found no
specific role of AIx in DM. However, JH Chow et al. [15]
recruited both diabetic and non-diabetic patients and re-
vealed that higher AIx@75 was universally associated with
PCI among CAD patients. Moreover, MT Schram et al.
[16] found that DM was associated with increased AIx.
No definitive conclusion has been made regarding the im-
pact of DM on AIx in the CAD population.
AIx is defined as a ratio of augmentation pressure and
pulse pressure. Therefore, it is necessary to consider both
elements when analyzing its changes. It has been proposed
that global stiffening of arteries augments systolic pressure
mainly through the increase of wave reflections, whereas
local stiffening of proximal aorta amplifies forward pres-
sure wave [4, 17]. Studies concerning arterial pathology in
diabetic subjects discovered that DM may lead to prefer-
ential increase of large artery stiffness, resulting in lower
reflection magnitude [3]. Based on such potential mecha-
nisms and our findings, we suggest that diabetic patients
may experience more prominent stiffening of the proximal








SBP(mmHg) 130.1 ± 17.3 127.8 ± 17.5 133.2 ± 16.6 0.037*
DBP(mmHg) 74.9 ± 11.1 74.8 ± 10.9 75.0 ± 11.5 0.884
CASP(mmHg) 120.3 ± 16.6 118.1 ± 16.5 123.1 ± 16.5 0.044*
MAP(mmHg) 91.9 ± 12.1 91.3 ± 12.8 92.8 ± 11.2 0.387
AP(mmHg) 11.8 ± 7.5 11.9 ± 7.3 11.7 ± 7.9 0.840
Central PP(mmHg) 45.4 ± 13.0 43.5 ± 11.9 48.1 ± 13.9 0.130
Brachial PP(mmHg) 55.2 ± 14.0 53.2 ± 13.2 58.1 ± 14.5 0.130
PR(bpm) 67.7 ± 10.1 67.5 ± 10.3 67.8 ± 9.8 0.750
AIx(%) 77.8 ± 14.5 77.0 ± 14.0 79.0 ± 15.0 0.372
AIx@75(%) 74.9 ± 14.2 74.0 ± 14.3 76.1 ± 13.9 0.317
PRT(ms) 114.5 ± 27.0 116.1 ± 28.1 112.5 ± 25.4 0.374
*p value for comparison between the non-diabetic and diabetic groups; p < 0.05
indicates statistical significance. SBP systolic blood pressure, DBP diastolic
blood pressure, MAP mean arterial pressure, PP pulse pressure, PR pulse rate,
CASP central aortic systolic pressure, AP augmentation pressure, PRT peak
relative time
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aorta compared with their non-diabetic peers. As a conse-
quence, diabetes may blunt the correlation between AIx
and atherosclerosis-induced arterial stiffness in CAD.
Type 2 diabetes has been proven to be associated with
increased central artery stiffness [14, 16, 18]. In a large
population-based study, JA Chirinos et al. [19] con-
cluded that DM was associated with increased aortic
stiffening, but not with increased carotid stiffness. Sub-
jects with DM demonstrated a decreased reflection mag-
nitude. Prolonged exposure to hyperglycemia can lead to
protein glycation, collagen crosslinking and endothelial
dysfunction [20]. All of the abnormal changes have dele-
terious effects on arterial stiffness. Possibly, as DM pro-
gresses, these modifications can increase aortic stiffness
by a local effect on the arterial wall despite classical de-
terminants of arterial stiffness [14]. Accordingly, AIx
may not be the optimal estimation of arterial stiffness and
predictor of the severity of CAD in the diabetic population.
Future investigations should evaluate the predictive value of
AIx in distinct clinical scenarios. As for diabetic CAD pa-
tients, experimental research of pathological changes to the
aorta is warranted. Previous studies have found that in DM
patients, PP was an independent predictor of CAD [19]. Fu-
ture studies may identify other meaningful predictive indi-
ces (such as PP) for diabetic CAD patients. Moreover,
central hemodynamic parameters are presumably affected
by patient conditions such as impaired renal function
[21], so a comprehensive study including all central
Table 3 Odds ratios for the association between the central hemodynamic parameters and the risk of more severe CAD measured
by SYNTAX
Variables N SYNTAX >
22, N(%)
Univariate analysis Multivariate analysisa






AIx@75 1.064(1.027–1.103) 0.001 1.099(1.028–1.176) 0.006
AP 1.084(1.018–1.154) 0.012 0.938(0.837–1.051) 0.273





aindices that were statistically significant in the univariate logistic regression analysis were included in the multivariate analysis
Fig. 2 The correlation of AIx@75 and the severity of CAD measured by SYNTAX score according to type 2 diabetes in linear regression analysis
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hemodynamic status-related factors might be valuable
in the future.
Limitations
First, the present study was limited by its relatively small
sample size; thus, future research evaluating a larger
number of patients is necessary. Second, the study’s ob-
servational design, permitted potential confounders to
affect the result even after adjustment. Third, long-term
follow up studies should be implemented to explore the
possible predictive value of AIx for cardiovascular out-
comes in non-diabetic patients. Forth, the current study
didn’t record patient-reported duration of DM and DM-
related organ damage. It will be valuable to investigate
the impact of the duration or status of the disease on
the correlation in future research.
Conclusions
Aortic augmentation index is significantly related to the
severity of CAD and is an independent predictor of
more severe CAD. However, its value in DM population
was compromised, which might be related to DM-
specific arterial changes and clinical practitioners should
be aware of the fact.
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